2'-O-Methyl-P-thiouridylyl-(3'→5')-2'-deoxyadenosine, has identified to be the first orally bioavailable dinucleotide prodrugs for further therapeutic development against the hepatitis B virus (HBV).
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.